Published in Curr Opin Urol on January 01, 2012
Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol (2010) 2.68
Artificial urinary sphincter revision: the role of ultrasound. Urology (2013) 2.62
Contemporary management of postprostatectomy incontinence. Eur Urol (2011) 2.01
An artificial somatic-central nervous system-autonomic reflex pathway for controllable micturition after spinal cord injury: preliminary results in 15 patients. J Urol (2003) 1.73
Managing the urethra at transvaginal pelvic organ prolapse repair: a urodynamic approach. J Urol (2008) 1.67
Urodynamic studies in adults: AUA/SUFU guideline. J Urol (2012) 1.51
Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol (2005) 1.49
Molecular mechanisms for protein kinase A-mediated modulation of immune function. Cell Signal (2002) 1.45
FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J Immunol (2006) 1.43
Artificial urinary sphincter versus male sling for post-prostatectomy incontinence--what do patients choose? J Urol (2009) 1.30
American Urological Association Symptom Index for lower urinary tract symptoms in women: correlation with degree of bother and impact on quality of life. Urology (2003) 1.30
Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation. Eur J Immunol (2008) 1.28
Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn (2013) 1.17
Comparison of diagnostic criteria for female bladder outlet obstruction. J Urol (2006) 1.14
Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study. Mayo Clin Proc (2008) 1.11
Review article: Mid-urethral synthetic slings for female stress urinary incontinence. BJU Int (2010) 1.10
LPS-activated monocytes suppress T-cell immune responses and induce FOXP3+ T cells through a COX-2-PGE2-dependent mechanism. Int Immunol (2007) 1.09
Female urethral reconstruction. Urol Clin North Am (2011) 1.01
Female stress urinary incontinence: how do patient and physician perspectives correlate in assessment of outcomes? Curr Opin Urol (2006) 0.99
The male perineal sling: assessment and prediction of outcome. J Urol (2007) 0.95
Surgical management of Skene's gland abscess/infection: a contemporary series. Int Urogynecol J (2011) 0.95
Effect of tension-free vaginal tape and TVT-obturator on lower urinary tract symptoms other than stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.94
A urodynamics protocol to optimally assess men with post-prostatectomy incontinence. Neurourol Urodyn (2005) 0.90
Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the art. Rev Urol (2006) 0.90
Primary bladder neck obstruction in men and women. Rev Urol (2005) 0.90
Urinary incontinence. Prim Care (2010) 0.88
Pubovaginal sling and pelvic prolapse repair in women with occult stress urinary incontinence: effect on postoperative emptying and voiding symptoms. Urology (2002) 0.87
Treatment of post-prostatectomy incontinence with male slings in patients with impaired detrusor contractility on urodynamics and/or who perform Valsalva voiding. J Urol (2011) 0.87
Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder. Int Urogynecol J (2014) 0.87
Differentiation of naive CD4+ T cells into CD4+CD25+FOXP3+ regulatory T cells by continuous antigen stimulation. J Leukoc Biol (2008) 0.86
Patient perception of videourodynamic testing: a questionnaire based study. J Urol (2005) 0.86
Clinical impact of overactive bladder. Rev Urol (2002) 0.85
Midurethral slings for all stress incontinence: a urology perspective. Urol Clin North Am (2012) 0.85
Management of recurrent urinary tract infections in healthy adult women. Rev Urol (2013) 0.84
Repeat urethrolysis after failed urethrolysis for iatrogenic obstruction. J Urol (2003) 0.84
Defining efficacy in the treatment of overactive bladder syndrome. Rev Urol (2009) 0.84
Management of obstructive voiding dysfunction after incontinence surgery: lessons learned. Urology (2003) 0.83
Degree of bother caused by nocturia in women. Neurourol Urodyn (2004) 0.83
Outcomes of patients lost to followup after mid urethral synthetic slings--successes or failures? J Urol (2010) 0.81
Efficacy and tolerability of fesoterodine in women with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.81
Bladder-health diaries: an assessment of 3-day vs 7-day entries. BJU Int (2005) 0.81
Primary bladder neck obstruction in men, women, and children. Curr Urol Rep (2007) 0.80
Urodynamic differences between dysfunctional voiding and primary bladder neck obstruction in women. Urology (2012) 0.80
Recent advances in management of female lower urinary tract trauma. Curr Opin Urol (2003) 0.80
Management of Diverticular Disease in Scandinavia. J Clin Gastroenterol (2016) 0.79
Duloxetine: a new pharmacologic therapy for stress urinary incontinence. Rev Urol (2004) 0.79
Voiding dysfunction in young, nulliparous women: symptoms and urodynamic findings. Int Urogynecol J Pelvic Floor Dysfunct (2004) 0.78
Long-term continence after surgery--what can we tell patients? J Urol (2012) 0.78
Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder. Urology (2008) 0.78
Diagnosis and treatment of primary bladder neck obstruction in men. Curr Urol Rep (2005) 0.77
Comparison of urodynamic findings in women with anatomical versus functional bladder outlet obstruction. Female Pelvic Med Reconstr Surg (2013) 0.77
Onset of action of the β3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder. World J Urol (2014) 0.77
Correlation of abdominal leak point pressure with objective incontinence severity in men with post-radical prostatectomy stress incontinence. Neurourol Urodyn (2005) 0.76
Tolterodine for treatment of overactive bladder. Urol Clin North Am (2006) 0.76
Endoscopic evacuation of Durasphere. Urology (2003) 0.76
Editorial comment. Urology (2011) 0.75
Editorial comment. Urology (2011) 0.75
Reply: To PMID 24295256. Urology (2013) 0.75
Is There a Role for alpha-Blockers for the Treatment of Voiding Dysfunction Unrelated to Benign Prostatic Hyperplasia? Rev Urol (2005) 0.75
Transdermal therapy for overactive bladder: present and future. Rev Urol (2003) 0.75
Urodynamics for clinically suspected obstruction after anti-incontinence surgery in women. J Urol (2013) 0.75
Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial. Ann Surg (2017) 0.75
Urodynamic findings in women with insensible incontinence. Int J Urol (2012) 0.75
Vaginal granulation tissue secondary to bone anchors: experience in two patients. J Urol (2003) 0.75
Pelvic floor reconstruction: state-of-the-art and beyond. Urol Clin North Am (2004) 0.75
Fistulization between ectopic ureteral stump and uterus following nephroureterectomy: case report. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.75
Association between detrusor overactivity and postoperative outcomes in patients undergoing male bone anchored perineal sling. J Urol (2009) 0.75
Management of urinary retention and obstruction following surgery for stress urinary incontinence. Curr Urol Rep (2002) 0.75